ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
11.61
+0.22 (1.93%)
Oct 11, 2024, 4:00 PM EDT - Market closed
ClearPoint Neuro Market Cap
ClearPoint Neuro has a market cap or net worth of $320.39 million as of October 11, 2024. Its market cap has increased by 154.48% in one year.
Market Cap
320.39M
Enterprise Value
301.34M
1-Year Change
154.48%
Ranking
Category
Stock Price
$11.61
Market Cap Chart
Since May 22, 2012, ClearPoint Neuro's market cap has increased from $30.30M to $320.39M, an increase of 957.38%. That is a compound annual growth rate of 20.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 320.40M | 91.63% |
| Dec 29, 2023 | 167.20M | -19.62% |
| Dec 30, 2022 | 208.00M | -21.57% |
| Dec 31, 2021 | 265.20M | -1.08% |
| Dec 31, 2020 | 268.10M | 267.26% |
| Dec 31, 2019 | 73.00M | 337.13% |
| Dec 31, 2018 | 16.70M | -41.61% |
| Dec 29, 2017 | 28.60M | 132.52% |
| Dec 30, 2016 | 12.30M | -56.84% |
| Dec 31, 2015 | 28.50M | -41.84% |
| Dec 31, 2014 | 49.00M | -42.22% |
| Dec 31, 2013 | 84.80M | 10.42% |
| Dec 31, 2012 | 76.80M | 153.47% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 328.95M |
| AC Immune | 328.48M |
| Treace Medical Concepts | 327.12M |
| Inozyme Pharma | 324.96M |
| XOMA Royalty | 322.93M |
| Aldeyra Therapeutics | 319.09M |
| enGene Holdings | 317.91M |
| Immutep | 314.44M |